Valuation Merck & Co., Inc.

Equities

Market Closed - Nyse Other stock markets 01:30:02 12/09/2024 am IST			5-day change	1st Jan Change
114.71 ^USD	-0.54%		-0.94%	+5.22%

11/09	Merck: positive results for HPV vaccine	CF
11/09	Merck's HPV Vaccine Meets Main Goal in Phase 3 Study in Japanese Males	MT

Fiscal Period: December	2019	2020	2021	2022	2023	2024	2025	2026
Capitalization ¹	2,31,557	2,06,957	1,93,588	2,81,302	2,76,259	2,90,768	-	-
Change	-	-10.62%	-6.46%	45.31%	-1.79%	5.25%	-	-
Enterprise Value (EV) ¹	2,47,453	2,30,686	2,18,594	2,98,801	3,04,221	3,12,047	2,97,747	2,82,806
Change	-	-6.78%	-5.24%	36.69%	1.81%	2.57%	-4.58%	-5.02%
P/E ratio	23.9x	29.4x	14.9x	19.4x	779x	15.3x	12.7x	11.5x
PBR	9x	8.18x	5.07x	6.12x	7.34x	5.92x	4.68x	3.76x
PEG	-	-1.1x	0.2x	1.7x	-8x	0x	0.6x	1x
Capitalization / Revenue	4.94x	4.31x	3.97x	4.75x	4.6x	4.53x	4.25x	4x
EV / Revenue	5.28x	4.81x	4.49x	5.04x	5.06x	4.87x	4.35x	3.89x
EV / EBITDA	12.6x	11.2x	10.5x	11.3x	30.2x	11.1x	9.16x	8.13x
EV / EBIT	15.5x	13.6x	12.4x	13.3x	49x	12.6x	10.2x	8.89x
EV / FCF	24.8x	41.4x	25.2x	20.3x	33.3x	16.7x	12.7x	10.9x
FCF Yield	4.03%	2.41%	3.97%	4.92%	3.01%	6%	7.89%	9.14%
Dividend per Share ²	2.26	2.48	2.64	2.8	2.96	3.075	3.232	3.392
Rate of return	2.48%	3.03%	3.44%	2.52%	2.72%	2.68%	2.82%	2.96%
EPS ²	3.81	2.78	5.14	5.71	0.14	7.499	9.027	10.02
Distribution rate	59.3%	89.2%	51.4%	49%	2,114%	41%	35.8%	33.9%
Net sales ¹	46,840	47,994	48,704	59,283	60,115	64,122	68,430	72,627
EBITDA ¹	19,572	20,570	20,910	26,431	10,083	27,994	32,493	34,804
EBIT ¹	15,920	16,945	17,696	22,522	6,211	24,771	29,081	31,800
Net income ¹	9,843	7,067	13,049	14,519	365	18,812	22,854	25,668
Net Debt ¹	15,896	23,729	25,006	17,499	27,962	21,279	6,979	-7,962
Reference price ²	90.95	81.80	76.64	110.95	109.02	114.71	114.71	114.71
Nbr of stocks (in thousands)	25,45,984	25,30,034	25,25,944	25,35,396	25,34,023	25,34,809	-	-
Announcement Date	05/02/20	04/02/21	03/02/22	02/02/23	01/02/24	-	-	-

¹USD in Million²USD

Estimates

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E ratio	EV / Sales	EV / EBITDA	Yield (Y)	Capi. ($)
MERCK & CO., INC.	15.38x	4.89x	11.2x	+2.67%	29TCr
ELI LILLY AND COMPANY	58.11x	18.01x	43.74x	+0.58%	83TCr
NOVO NORDISK A/S	38.54x	13.43x	27.34x	+1.30%	58TCr
JOHNSON & JOHNSON	21.43x	4.63x	13.14x	+2.80%	40TCr
ABBVIE INC.	38.8x	7.32x	15.82x	+3.13%	34TCr
ROCHE HOLDING AG	16.05x	3.81x	9.97x	+3.66%	25TCr
ASTRAZENECA PLC	28.97x	5.21x	15.46x	+1.91%	25TCr
NOVARTIS AG	21.08x	4.99x	12.63x	+3.24%	23TCr
AMGEN INC.	50.67x	6.84x	11.97x	+2.79%	18TCr
PFIZER, INC.	21.83x	3.73x	10.2x	+5.60%	17TCr
Average	31.09x	7.29x	17.15x	+2.77%	35.24TCr
Weighted average by Cap.	35.69x	9.59x	22.49x	+2.21%